Molecularix Biolabs owl emblemMolecularixBiolabs
Research Library
PRECLINICAL

Dihexa

Also known as: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, PNB-0408

Neuropeptide ResearchCognitive Research
ClassificationSmall-molecule angiotensin IV-derived peptidomimetic studied in neurotrophic research.
TargetsHGF/c-Met potentiation models; Synaptogenesis assays

Molecular Overview

Dihexa is an angiotensin IV analog investigated in preclinical models for potentiation of hepatocyte growth factor (HGF)/c-Met signaling.

Mechanistic Background

Reported to enhance HGF/c-Met-dependent signaling in cell and rodent models.

What Researchers Study

Preclinical cognition-model literature from academic groups.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

No human data; strictly an experimental tool compound.

Scientific References

Documentation

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.